|
AstraZeneca builds pipeline with $232 million Synairgen asthma deal
Yahoo News LONDON (Reuters) – AstraZeneca has struck a deal worth up to $232 million in milestone payments to acquire rights to a drug from Synairgen for treating respiratory tract viral infections in patients with severe asthma. Britain's second-biggest … AstraZeneca Licences Asthma Exacerbation Treatment From Synairgen AstraZeneca licenses rights to Synairgen asthma drug Synairgen shares soar on AstraZeneca asthma deal |
View full post on asthma – Google News